Approval for the minimed 5300 system. this device is indicated for the following: minimed 530g system - the minimed 530g system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for themanagement of diabetes mellitus in persons, sixteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. the minimed 530g system can be programmed to automatically suspend delivery of insulin when the sensor glucose value falls below a predefined threshold value. for additional information please refer to approval order.